Company Filing History:
1 out of 1,651 
1 out of 26 
1 out of 229 Years Active: 2013-2021
Title: The Innovative Contributions of Boris Ivandic
Introduction
Boris Ivandic is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the prediction and diagnosis of critical health conditions. With a total of 2 patents, his work has the potential to impact patient care and treatment outcomes.
Latest Patents
One of Boris Ivandic's latest patents is a method for predicting the prognosis of sepsis. This innovative approach involves measuring the sCD14-ST level in a sample, which serves as a superior marker compared to procalcitonin for predicting outcomes in sepsis patients. Another significant patent focuses on diagnosing acute pulmonary embolism (PE). This method includes determining the amounts of D-dimer, natriuretic peptides, and cardiac troponin in a subject's sample, allowing for accurate diagnosis and therapy monitoring.
Career Highlights
Throughout his career, Boris Ivandic has worked with prominent companies in the medical field, including Roche Diagnostics Operations, Inc. and LSI Medience Corporation. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Boris has collaborated with esteemed professionals in his field, including Eberhard Spanuth and Takeshi Matsuya. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Boris Ivandic's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving patient care. His work in predicting sepsis and diagnosing pulmonary embolism showcases the importance of advancements in medical technology.